A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 74.50
+0.50 (0.68%)
Aug 26, 2026, 1:30 PM CST
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.52 billion as of August 25, 2026. Its market cap has decreased by -24.97% in one year.
Market Cap
2.52B
Enterprise Value
2.20B
Revenue
887.93M
Ranking
n/a
PE Ratio
13.71
Stock Price
74.50
ChartMarket Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.52B, an increase of 65.49%. That is a compound annual growth rate of 14.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 2.52B | -14.70% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.32B |
| Bonraybio | 2.98B |
| Applied BioCode | 2.88B |
| Medimaging Integrated Solution | 2.51B |
| Wellell | 2.49B |
| Dynamic Medical Technologies | 2.04B |
| OK Biotech | 2.04B |
| Taiwan Biomaterial | 1.48B |